Severe Injection Site Reactions After Subcutaneous Administration of Sayana®: A Retrospective, Post-Marketing Analysis of WHO and Swiss Spontaneous Pharmacovigilance Reports. Swiss Med Wkly 2017, 147 (1920), w14432. https://doi.org/10.4414/smw.2017.14432.